Economic Analysis for Final Effluent Guidelines and Standards for the Pharmaceutical Industry, Draft Report.
This economic analysis (EA) examines compliance costs and economic impacts resulting from the U.S. Environmental Protection Agency's (EPA's) Final Effluent Limitations Guidelines and Standards for the Pharmaceutical Manufacturing Industry Point Source Category, hereinafter known as the Final Pharmaceutical Industry Effluent Guidelines. It also investigates the costs and impacts associated with an air rule requiring Maximum Achievable Control Technology (MACT) to control air emissions, both separately and together with the Final Pharmaceutical Industry Effluent Guidelines.
|Office of Water|
|No suboffice specified|
|Environmental Analysis Division|
|Economic Impact Assessment|
|Eastern Research Group, Inc.|